Abstract
The Spectra 22 Speech Processor and spectral peak (SPEAK) speech-coding strategy provide Nucleus 22 Channel Cochlear Implant (Cochlear, Corp., Englewood, Colo.) users with a better understanding of speech than the previous Mini Speech Processor and Multipeak (MPEAK) speech-coding strategy. On the NU-6 Monosyllabic Word Test, subjects scored 13% higher for words and 14% higher for phonemes with the SPEAK strategy than with the MPEAK strategy. On the Connected Speech Test and the CID Everyday Sentence Test, subjects scored 32% and 37% higher, respectively, with SPEAK than with MPEAK.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Paper Title
Journal
Date
